The most comprehensive and go-to place for all short selling reseach reports online.
Currently a total of 275 research reports from 14 investment research firms has been aggregated, with new reports being added and updated constantly
ALL
Fuzzy Panda Research(8)
Hindenburg Research(52)
MuddyWaters(44)
Blue Orca Capital(35)
Gotham City Research LLC(11)
Anonymous Analytics(5)
J Capital Research(26)
Grizzly Research LLC(22)
Jehoshaphat Research(10)
Culper Research(20)
Ningi Research(4)
Night Market Research(14)
Ontake Research(2)
Bonitas Research(22)
ALL
0067(1)
0607(1)
0773(1)
1044(1)
1228(1)
1259(1)
1360(6)
1619(1)
1636(1)
1717(1)
1910(1)
1999(1)
2018(1)
2020(1)
2200(1)
3823(1)
3836(1)
3998(1)
404(1)
4587(1)
496(1)
555(1)
6186(1)
6594(1)
669.HK(1)
6863(1)
8207(2)
867(1)
ACB(1)
ACMR(1)
AGFY(1)
AHCO(1)
AHG(1)
AMEH(1)
AMT(1)
AMTX(1)
AOS(1)
APHA(1)
AR4(1)
AR4.DE(1)
ARMC(1)
ARRY(1)
ATEC(1)
ATER(1)
ATRC(1)
BCOR(1)
BDSI(1)
BE(1)
BEKE(1)
BGNE(1)
BLA(1)
BLNK(1)
BOO(1)
BRP(1)
BTBT(1)
BTCM(1)
BUR(1)
BWXT(1)
BYSI(1)
CBAT(1)
CCME(1)
CCRC(1)
CDXC(1)
CELH(1)
CGN(1)
CLOV(1)
CLSK(1)
CMC(1)
CMED(1)
CO(1)
CORT(1)
CORZ(1)
CRIUF(1)
CRMD(1)
CRTO(1)
CSSE(1)
CYDY(1)
DATS(1)
DGW(1)
DKNG(1)
DNMR(1)
DOS(1)
DOYU(1)
DVA(1)
EBIX(1)
EBON(1)
EDU(1)
EHTH(1)
EIGU(1)
ELMS(1)
EMO(1)
ENOB(1)
ENPH(1)
EROS(1)
EVER(1)
EVGO(1)
FANH(1)
FCEL(1)
FD(1)
FFIE(1)
FIZZ(1)
FMCN(1)
FRGT(1)
FRSX(1)
FUV(1)
GAU(1)
GDS(2)
GFRE(1)
GGR(1)
GNPX(1)
GNUS(1)
GNW(1)
GOTU(2)
GOW(1)
GRWG(1)
GWH(2)
HASI(2)
HFFG(1)
HMBL(1)
HPR(1)
HROW(2)
HTHT(1)
HYLN(1)
HYZN(1)
IBAT(1)
IDEX(2)
IIPR(1)
INGN(1)
INPX(1)
INS(1)
IPO(1)
IQE(1)
ITP(1)
JCOM(1)
JD(1)
JKS(1)
KERN(1)
KIDS(1)
KNDI(1)
KRZ(1)
LICY(1)
LK(1)
LKE(1)
LKM(1)
LLEN(1)
LMFD(1)
LMND(1)
LOOP(1)
LTS(1)
LX(1)
MARA(2)
MARK(1)
MDCA(1)
MED(1)
MFC(1)
MNSO(1)
MP(2)
MPLN(1)
MULN(1)
MVMD(1)
MXL(1)
N/A(1)
NAK(1)
NB2(1)
NBEV(1)
NEA(1)
NEWP(1)
NEXCF(1)
NG(1)
NIO(1)
NISN(1)
NKLA(1)
NMC(1)
NNOX(1)
NOBGY(1)
NRGV(1)
NTRA(1)
NYMX(1)
OLAG(1)
ONDS(1)
OPK(1)
OPRA(1)
ORA(1)
OSIS(1)
OTRK(1)
PCLO(1)
PCYO(1)
PETS(1)
PGLC(1)
PGNY(1)
PKK(1)
PLL(2)
PLSE(1)
PLTK(1)
PRED(1)
PRTA(1)
PUMP(1)
PVBC(1)
QPP(1)
RFF(1)
RIDE(1)
RINO(1)
RIOT(1)
ROLTA(1)
RUN(1)
S30(1)
SAX(1)
SDC(1)
SEK(1)
SEV(1)
SGLY(1)
SKYS(1)
SLI(2)
SOL(1)
SOS(1)
SPI(1)
SPRD(1)
SRNE(2)
SSTI(1)
STAA(1)
STEM(1)
STJ(1)
SY(1)
TAL(1)
TELIA(1)
TFC(1)
TGLS(1)
TMC(1)
TMCI(1)
TRE(1)
TRUL(1)
TSP(1)
TTSH(1)
TWTR(1)
UAVS(1)
UNH(1)
UTA(1)
VBIV(1)
VERI(1)
VERU(1)
VIEW(1)
WELL(1)
WINS(1)
WKHS(1)
WORX(1)
WTC(1)
WU(1)
WUBA(1)
XL(1)
XMTR(1)
XXII(1)
YMM(1)
YRIV(1)
YY(1)
ZEN(1)
ZNOG(1)
ZTO(1)
ZYXI(1)
Current Share Price: 1.610
Hindenburg Research
Initial Report Date(2020/04/17)Share Price:6.720
Initial Report Date(2020/04/17)Share Price:6.720
SCWorx: Evidence Points to its Massive COVID-19 Test Deal Being Completely Bogus, Price Target Back to $2.25 Or Lower
Details Link > We believe the Covid-19 hype surrounding SCWorx is completely bogus and we predict shares will soon return to the $2.25 price level they were at prior to the hype.
We also think shares risk being halted and ultimately could move far lower than $2.25 if/when regulators investigate the company’s potentially nefarious business practices at a time when our country and its citizens are arguably at their most vulnerable. We’re offended by how egregious this appears, not only as investors, but as Americans.
By wantattse
Start